ProUroCare Medical (GICI) Appoints Life Science Veteran as Interim Chief Operating Officer  
12/13/2012 10:23:42 AM

MINNEAPOLIS--(BUSINESS WIRE)--ProUroCare Medical Inc. (OCTQB: PUMD), developer of the FDA-approved ProUroScan™ prostate imaging system, announced that life sciences veteran Doris Engibous has entered into a contract to act as its interim Chief Operating Officer. Ms. Engibous’ primary assignment during this interim period is to direct activities leading to a 510(k) submission for a reusable probe for the ProUroScan system, the placements of systems at key opinion leader sites, and the production of systems in advance of market launch. Chairman of the Board, Dr. Michael Chambers, commented, “We are delighted to have someone with Doris’ track record of focus on product development and market adoption with financial and operational experience in both emerging and established businesses.”